Boston Scientific (BSX) Reports In-Line Q4 EPS
Tweet
Share
E-mail
Get Alerts BSX Hot Sheet
Price: $44.33 -2.12%
Revenue Growth %: +6.3%
Financial Fact:
Other, net: -33M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +6.3%
Financial Fact:
Other, net: -33M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Boston Scientific (NYSE: BSX) reported Q4 EPS of $0.34, in-line with the analyst estimate of $0.34. Revenue for the quarter came in at $2.41 billion versus the consensus estimate of $2.38 billion.
For earnings history and earnings-related data on Boston Scientific (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- NVE Corporation names new CEO and expands board to seven members
- Ennis (EBF) Reports In-Line Q1 EPS
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
